Opportunity ID: 333311

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-21-032
Funding Opportunity Title: Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trials Not Allowed
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Agriculture
Consumer Protection
Food and Nutrition
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 05, 2021
Last Updated Date: May 05, 2021
Original Closing Date for Applications: Jul 06, 2021
Current Closing Date for Applications: Jul 06, 2021
Archive Date: Aug 05, 2021
Estimated Total Program Funding: $8,000,000
Award Ceiling: $4,000,000
Award Floor: $0

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
Public housing authorities/Indian housing authorities
State governments
Independent school districts
County governments
Special district governments
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility: Higher Education Institutions

Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education:

o Hispanic-serving Institutions

o Historically Black Colleges and Universities (HBCUs)

o Tribally Controlled Colleges and Universities (TCCUs)

o Alaska Native and Native Hawaiian Serving Institutions

o Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Nonprofits Other Than Institutions of Higher Education

Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
For-Profit Organizations

Small Businesses
For-Profit Organizations (Other than Small Businesses)
Governments

State Governments
County Governments
City or Township Governments
Special District Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
U.S. Territory or Possession
Other

Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Native American Tribal Organizations (other than Federally recognized tribal governments)
Faith-based or Community-based Organizations
Regional Organizations
Non-domestic (non-U.S.) Entities (Foreign Institutions)

Additional Information

Agency Name: Food and Drug Administration
Description:

CBER, FDA seeks to support the development of innovative pathogen reduction technologies for whole blood and blood components to prevent transfusion-transmitted infectious diseases. 

Link to Additional Information: Full Announcement of RFA-FD-21-032 on NIH Guide for Grants and Contracts
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Gordana Zuber

Grant Management Specialist

Phone 301-348-1747
Email:gordana.zuber@fda.hhs.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: Gordana Zuber
Grant Management Specialist
Phone 301-348-1747
Email: gordana.zuber@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 RFA-FD-21-032 FORM F PKG00266925 May 05, 2021 Jul 06, 2021 View

Package 1

Mandatory forms

333311 RR_SF424_2_0-2.0.pdf

333311 PHS398_CoverPageSupplement_5_0-5.0.pdf

333311 RR_OtherProjectInfo_1_4-1.4.pdf

333311 PerformanceSite_2_0-2.0.pdf

333311 RR_KeyPersonExpanded_2_0-2.0.pdf

333311 RR_Budget_1_4-1.4.pdf

333311 PHS398_ResearchPlan_4_0-4.0.pdf

333311 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

333311 RR_SubawardBudget30_1_4-1.4.pdf

333311 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T22:39:21-05:00

Share This Post, Choose Your Platform!

About the Author: